DNTH Operating Cash Flow (Statement)
Dianthus Therapeutics Inc · Operating Cash Flow (Statement)
DNTH Operating Cash Flow (Statement)
Latest reported-$155.38Mperiod ending
DNTH TTM Cash from Operations (-$22.26M → -$155.38M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DNTH operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -155,375,000 | |
| -130,286,000 | |
| -129,060,000 | |
| -109,521,000 | |
| -100,233,000 | |
| -90,869,000 | |
| -78,180,000 | |
| -62,590,000 | |
| -39,826,000 | |
| -30,029,000 | |
| -25,372,000 | |
| -22,369,000 | |
| -7,491,000 | |
| -19,613,000 | |
| -29,070,000 | |
| -35,909,000 | |
| -66,351,000 | |
| -62,498,000 | |
| -59,531,000 | |
| -57,574,000 | |
| -57,935,000 | |
| -64,140,000 | |
| -64,023,000 | |
| -65,917,000 | |
| -62,996,000 | |
| -58,824,000 | |
| -57,103,000 | |
| -54,100,000 | |
| -53,142,000 | |
| -47,218,000 | |
| -41,886,000 | |
| -37,494,000 | |
| -32,388,000 | |
| -27,837,000 | |
| -22,263,000 |